Re: Piet Ost, Shankar Siva, Sigmund Brabrabd, et al. Salvage Metastasis-directed Therapy Versus Elective Nodal Radiotherapy for Oligorecurrent Nodal Prostate Cancer Metastases (PEACE V–STORM): A Phase 2, Open-label, Randomised Controlled Trial. Lancet Oncol 2025;26:695–706

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 9604c54e1e739e70-LAX IP: 118.31.43.22 UTC time: 2025-07-16T22:00:08+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

EUROPEAN UROLOGY FOCUS

Like

Share Bookmark

0 0 0 0 0 0 0

More from this channel

Re: Piet Ost, Shankar Siva, Sigmund Brabrabd, et al. Salvage Metastasis-directed Therapy Versus Elective Nodal Radiotherapy for Oligorecurrent Nodal Prostate Cancer Metastases (PEACE V–STORM): A Phase 2, Open-label, Randomised Controlled Trial. Lancet Oncol 2025;26:695–706

Comments (0)